Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Share subscriptions based on Nanoform Finland Plc’s multiple Stock Option Programs

Company release Nanoform Finland Plc April 12, 2022 07:00 p.m. Finnish time / 06:00 p.m. Swedish time Share subscriptions based on Nanoform Finland Plc’s multiple Stock Option Programs Helsinki, Finland – Between March 17 and March 31, 2022, a total of 163,500 Nanoform Finland Plc’s (the “Company” or “Nanoform“) new shares have been subscribed for with the Company’s 1/2019, 2/2019, 3/2019, 5/2019 and 1/2020 stock options programs. The entire subscription price for subscriptions made with the stock options of EUR 203,500 will be entered in the Company’s reserve for invested

Invitation to conference call and webcast presentation of Dometic’s interim report for the first quarter 2022

Dometic Group AB (publ) will publish its interim report for the first quarter 2022 at around 08.00 CEST on Thursday, April 28, 2022. On the same day at 10.00 CEST, Dometic will host a conference call and webcast to present the results. The presentation can be followed live via webcast and will also be available afterwards. The presentation will be held in English. The report and the presentation material will be available on Dometic’s website, https://www.dometicgroup.com/en/investors 

#22-130 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

#22-129 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

DanCann Pharma A/S Announces the appointment of Louise Conradsen as new Chief Executive Officer to accelerate growth of CannGros ApS

COPENHAGEN, Denmark, 12 April 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by cannabinoids, hereby announce that the Company has recruited and appointed its new Chief Executive Officer (“CEO”), Louise Conradsen, for the subsidiary CannGros ApS (“CannGros”) to elevate CannGros to a significantly higher commercial level strengthening the product portfolio and pipeline. Louise Conradsen will start in her new function with effect from 10th May 2022.Louise Conradsen is a commercial management professional with more than eighteen years of

DanCann Pharma A/S: NOTICE OF ANNUAL GENERAL MEETING

The Board of Directors hereby convenes the annual general meeting of DanCann Pharma A/S, CVR-no. 39 42 60 05 (“Company”), to be held on Thursday, 27 April 2022 at 09:00 am (CET) at DanCann Pharma A/S’ address, Rugvænget 5, DK-6823 Ansager The agenda for the annual general meeting is as follows: 1. The chairman’s report on the activities of the Company in the past financial year 2. Adoption of the annual report for 2021 3. Application of profit or covering of loss pursuant to the adopted annual report for 2021 4. Election of members of the Board of Directors 5. Election

DanCann Pharma A/S: Independent auditor's report

Opinion We have audited the consolidated financial statements and the parent financial statements of Dancann Pharma A/S for the financial year 01.01.2021 - 31.12.2021, which comprise the income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies, for the Group as well as the Parent, and the consolidated cash flow statement. The consolidated financial statements and the parent financial statements are prepared in accordance with the Danish Financial Statements Act. In our opinion, the consolidated financial statements and

DanCann Pharma A/S publishes Annual Report 2021

COPENHAGEN, Denmark, 12 April 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by cannabinoids, hereby announce that The Board of Directors and the Chief Executive Officer of DanCann Pharma publishes the annual report of the year 2021. The annual report is available after today's trading on the Spotlight Stock Market, and hereby available in this press release and on the website of DanCann Pharma.For more information, visit: https://www.dancann.com/investor-relations-ir/general-meetings.  Disclaimer Some statements in this release

FISKARS CORPORATION: ACQUISITION OF OWN SHARES 12.04.2022

Fiskars Corporation   Stock Exchange Release 12.04.2022 at 18:30 EET/EEST   FISKARS CORPORATION: ACQUISITION OF OWN SHARES 12.04.2022   Date 12.04.2022  Exchange transaction Buy  Share class FSKRS  Amount  5,700  Average price/share 20.3459 EURHighest price/share 20.5000 EURLowest price/share 20.1500 EURTotal price 115,971.63 EUR        The shares held by Fiskars Corporation on 12.04.2022:   FSKRS 499,563       On

Baseload Capital seeks approval from bondholders regarding certain amendments to the terms and conditions of its MSEK 500 senior secured green bonds

Baseload Capital Sweden AB (publ) (“Baseload”) today announces that it is, through a written procedure, soliciting approval from holders of its bonds (the “Bondholders”) with ISIN SE0011923267 (the “Bonds”) to make certain amendments to the terms and conditions of the Bonds.Baseload has requested that Nordic Trustee & Agency AB (publ), acting in its capacity as agent (the “Agent”) for the Bondholders, initiates a written procedure in accordance with the terms and conditions of the Bonds. The purpose of the written procedure is for the Bondholders to grant consent to certain amendments to

ABS Publishes Insights on Vessel Connectivity Technologies

(HOUSTON) The demands on vessel connectivity driven by smart, autonomous and remote-control functions are explored in the latest addition to ABS’ industry-leading series of guidance on key maritime technologies. Insights into Vessel Connectivity discusses communication technologies available and provides guidance to vessel owners, operators and system vendors in ensuring they are equipped to meet current and future demand. The publication reviews the relevant regulations and industrial standards on vessel connectivity, as well as future technology development and challenges. “The ship-

Smoltek's Nomination Committee proposes the election of two new Board members

This press release is an English version of the previously published Swedish version, which has interpretive precedence. Smoltek Nanotech Holding AB (“Smoltek”) announces that the company's Nomination Committee proposes Edvard Kälvesten and Per Zellman to be elected as new Board members at the Annual General Meeting on May 12, 2022. The proposed members are deemed to provide the Board with valuable expertise in company development as well as industrialization and commercialization of disruptive technology.Smoltek continues to develop from a research-driven company to an innovative

Why auditors should stop choosing convenience over security

USING multiple channels to collaborate with clients could lead to data breaches and financial losses, according to a new survey commissioned by Ideagen Plc.According to the survey, of 547 accounting and advisory professionals in the UK and US, auditors are predominately choosing convenience over security when sharing files with clients and each other. Email and Microsoft Teams were found to be the most used file sharing methods among auditors, due to their convenience and ease of use, despite the fact 87 per cent have use of a client portal within their organisation. While this is the

Össur hf: Q1 2022 Results - Conference Call Tuesday 26 April at 9:00 CEST

Announcement no. 23/2022 12 April 2022 Conference call on Tuesday 26 April at 9:00 CEST / 7:00 GMT / 3:00 ET Össur will publish its financial results for Q1 2022 prior to market opening on Tuesday 26 April. That same day at 9:00 CEST, Össur will host a conference call where Sveinn Solvason, President and CEO, will present and discuss the results of the quarter. The conference call will be conducted in English. A webcast can be followed on the Össur website: http://www.ossur.com/investors To participate in the conference call, please call one of the following telephone numbers:

Raisio plc: Organizing meeting of the Board of Directors

Raisio plc, Stock Exchange Release, 12 April 2022 At its meeting held after the Annual General Meeting 12 April 2022, the Board of Directors re-elected Arto Tiitinen as its Chairman and Ann-Christine Sundell as its Deputy Chairman. The Board also decided on its committees as follows: Ann-Christine Sundell was re-elected as the Chairman and Leena Niemistö and Pekka Tennilä as members of the Audit Committee. Arto Tiitinen was re-elected as the Chairman and Erkki Haavisto and Leena Niemistö as members of the People Committee. All members of the committees are independent

Change in Granted Options

Oslo, 12 April 2022: With reference to the option program for Norwegian Energy Company ASA ("Noreco" or the "Company"), as approved by the general meeting of the Company on 8 November 2018 and later amended, the number of granted options has, due to the exercise of options held by a former member of the executive team, been reduced by 100,000 to 462,202, with 450,000 options remaining to be granted under the program, each option giving the right to acquire or subscribe for one share in the Company upon exercise. Contact:Cathrine Torgersen, EVP Investor Relations & ESGEmail: ct@noreco.

Pexip Holding ASA: Revised Statement of the Nomination Committee

Reference is made to the notice for the annual general meeting published on March 31, 2022 for the annual general meeting in Pexip Holding ASA to be held on April 21, 2022 . Following the notice, the Nomination Committee has revised its proposed board composition by recommending Asta Ellingsen Stenhagen to be appointed as a new director instead of Iselin Nybø. Updated proxy forms and the amendment to the proposal from the Nomination Committee are attached and can be found on https://investor.pexip.com/corporate-governance/annual-general-meeting. Shareholders who have already submitted proxy

Katalysen Ventures AB (publ) announces oversubscribed listing issue

On April 10, 2022, the subscription period in Katalysen Ventures AB's (publ) ("Katalysen" or "the Company") new share issue prior to listing on Spotlight Stock Market (the "Listing Issue") ended. A total of approximately SEK 12.5 million was subscribed for in the Listing Issue, corresponding to a subscription ratio of approximately 113 percent. The company will thus receive approximately 130 new shareholders and approximately SEK 11 million before issue costs. Settlement notes are scheduled to be sent today, April 12, 2022. The first day of trading in Katalysen's share on Spotlight Stock

Storytel’s Board revises proposals to the Annual General Meeting 2022

The Board of Storytel AB (publ) has, following dialogues with the company's major institutional shareholders, revised its proposed resolution on adoption of a long-term performance based incentive program for key employees and proposed resolution on extension of outstanding employee stock option programs to the Annual General Meeting on 4 May 2022.The Board revises its proposals under item 12 and 13 as included in the notice to the Annual General Meeting, published on 4 April 2022. The revised proposal under item 12 entails that the CEO, group management and key employees with additional

Invitation to webcasted telephone conference – Q1 2022

BillerudKorsnäs’ interim report for the first quarter 2022 will be published on Thursday 5 May at around 07.00 CET.BillerudKorsnäs’ President and CEO Christoph Michalski and CFO Ivar Vatne will present the interim report via a webcasted telephone conference on the same day at 9.00 CET. The presentation will be held in English and will be followed by a Q&A session.The presentation can be followed on https://edge.media-server.com/mmc/p/8fiz98ap. To participate via telephone and thereby be able to ask questions, please use any of the following telephone numbers and pin code 2282794#.

Notice of Annual General Meeting in Moberg Pharma AB (publ)

Shareholders in Moberg Pharma AB (publ), reg. no. 556697-7426, (the “Company”) are hereby convened to the Annual General Meeting on 16 May 2022.Due to the coronavirus and in an effort to reduce the spread, the Board of Directors has resolved that the Annual General Meeting will be held without the physical presence of shareholders, representatives and third parties, and that the shareholders will only be able to exercise their voting rights through postal voting in accordance with the instructions specified below. Information regarding the resolutions passed by the Annual General Meeting

Karo Pharma publishes the 2021 annual report

Today, on 12 April 2022, Karo Pharma is publishing its annual report for 2021 on the company’s website, www.karopharma.com.     For further information, please contact:Lisa Westerdahl, Head of Corporate Communication, 073-329 70 04, lisa.westerdahl@karopharma.comJon Johnsson, CFO, 073-507 88 61, jon.johnsson@karopharma.com     The Annual Report is published in Swedish and English. The Swedish version represents the original version and has been translated into English.   This information is information that Karo Pharma is obliged to make public pursuant to the

SkartaNYAB Plc: Notice to the Annual General Meeting

SkartaNYAB PlcCOMPANY ANNOUNCEMENT12.04.2022 at 16:00SkartaNYAB Plc: Notice to the Annual General Meeting Shareholders of SkartaNYAB Plc (Business ID: 2393685-6) are hereby summoned to the Annual General Meeting that will be held on Tuesday, 3 May 2022, at 11:00 am. The location of the meeting will be Villa Hannala, Kahvelitie 1, Oulu. The reception of persons who have registered for the meeting, as well as the distribution of voting tickets, will be started at 10:45 am. The meeting will be held in Finnish. A. MATTERS ON THE AGENDA OF THE ANNUAL GENERAL MEETING The following

There are no items matching the current filter
There are no more items matching the current filter
Back to top